Columbus Circle Investors’s Abiomed Inc ABMD Stock Holding History

Columbus Circle Investors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-110,983	Closed	-$31.7M	–	186
2019 Q1	$31.7M	Sell	110,983 -61,478	-36%	-$20.4M	0.81%	58
2018 Q4	$56.1M	Buy	172,461 +33,645	+24%	+$11.7M	1.59%	13
2018 Q3	$62.4M	Buy	138,816 +74,374	+115%	+$29.3M	1.25%	18
2018 Q2	$26.4M	Buy	64,442 +41,403	+180%	+$15M	0.54%	74
2018 Q1	$6.7M	Buy	+23,039	New	+$5.84M	0.14%	148
2017 Q1	–	Sell	-130,516	Closed	-$14.7M	–	318
2016 Q4	$14.7M	Buy	130,516 +35,480	+37%	+$4.11M	0.19%	111
2016 Q3	$12.2M	Sell	95,036 -25,057	-21%	-$3M	0.13%	136
2016 Q2	$13.1M	Buy	120,093 +24,052	+25%	+$2.39M	0.13%	147
2016 Q1	$9.11M	Buy	+96,041	New	+$8.11M	0.08%	187

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Columbus Circle Investors's ABMD Position: Q2 2019 in Review

Columbus Circle Investors sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 110,983 shares — an estimated $31.7M sold.

Columbus Circle Investors first reported a position in ABMD in Q1 2016 and held it in 9 quarters. The position peaked at $62.4M in Q3 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

Columbus Circle Investors reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
Columbus Circle Investors sold 110,983 Abiomed Inc shares in Q2 2019, an estimated $31.7M.
Columbus Circle Investors first reported a position in Abiomed Inc in Q1 2016 and held it in 9 quarters.
Columbus Circle Investors's Abiomed Inc position peaked at $62.4M in Q3 2018.
484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Columbus Circle Investors's 13F filing for Q2 2019, filed 2 Aug 2019.